Adult precursor B lymphoblastic leukemia in Shanghai, China: Characterization of phenotype, cytogenetics and outcome for 137 consecutive cases

International Journal of Hematology

Volumn 89, Issue 4, 2009, Pages 431-437

  Bao, Liming ^a,b,c   Gross, Sherilyn A ^a,d   Ryder, John ^e   Wang, Xiaoqin ^a,f   Ji, Meirong ^f   Chen, Yan ^a   Yang, Yongchen ^a   Zhu, Saijuan ^a   Irons, Richard D ^a,c,d,e  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Cinpathogen Inc   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f FUDAN UNIVERSITY   (China)

Author keywords

BCR ABL; CD10; Cytogenetics; FISH; Ph chromosome; Precursor B cell ALL

Indexed keywords

ASPARAGINASE; BCR ABL PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHINA; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DRUG RESPONSE; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN CELL; KARYOTYPE EVOLUTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRE B LYMPHOCYTE; SEX RATIO; AGE DISTRIBUTION; CHROMOSOME ABERRATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SEXUAL DEVELOPMENT; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHINA; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEX CHARACTERISTICS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67449136035     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0283-8     Document Type: Article

References (30)

1. JE Cortes HM Kantarjian 1995 Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy Cancer 76 2393 2417
2. M Velizarova D Popova E Hadjiev 2006 Molecular-cytogenetic aberrations in B-cell adult acute lymphoblastic leukemia (B-ALL)-frequency and correlation with immunophenotype Turk J Hematol 23 151 157
3. Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
4. J Wang L Young W Win CR Taylor 2005 Distribution and Zap-70 Expression of WHO Lymphoma Categories in Shanxi, China: a Review of 447 Cases Using a Tissue Microarray Technique Appl Immunohistochem Mol Morphol 13 323 332
5. S Gross X Zhu L Bao 2008 A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China Int J Hematol 88 2 165 173
6. N Gokbuget D Hoelzer 2002 Recent approaches in acute lymphoblastic leukemia in adults Rev Clin Exp Hematol 6 114 141 (Pubitemid 34887259)
7. B Lenormand MC Bene JF Lesesve 1998 PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe D'etude Immunologique Des Leucemies Leuk Lymphoma 28 329 342
8. SA Armstrong AT Look 2005 Molecular genetics of acute lymphoblastic leukemia J Clin Oncol 23 6306 6315
9. CD Bloomfield LM Secker-Walker AI Goldman 1989 Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia Cancer Genet Cytogenet 40 171 185
10. H Dombret J Gabert JM Boiron 2002 Outcome of treatment in adults with philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multicenter Lala-94 trial Blood 100 2357 2366
11. S Faderl HM Kantarjian DA Thomas 2000 Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia Leuk Lymphoma 36 263 273
12. BS Ko JL Tang FY Lee 2002 Additional chromosomal abnormalities and variability of BCR breakpoints in philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan Am J Hematol 71 291 299
13. RA Larson RK Dodge CP Burns 1995 A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group b study 8811 Blood 85 2025 2037
14. LM Secker-Walker JM Craig 1993 Prognostic implications of breakpoint and linage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review Leukemia 7 147 151
15. M Wetzler RK Dodge K Mrozek 2004 Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the cancer and leukaemia group B Br J Haematol 124 275 288
16. B Gleissner H Rieder E Thiel 2001 Prospective BCR-ABL analysis by polymerase chain reaction (RR-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data Leukemia 15 1834 1840
17. A de Labarthe P Rousselot F Huguet-Rigal 2007 Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the Graaph-2003 study Blood 109 1408 1413
18. S Lee YJ Kim CK Min 2005 The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 105 3449 3457
19. PP Piccaluga G Martinelli M Rondoni G Visani M Baccarani 2006 Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia Expert Opin Biol Ther 6 1011 1022
20. B Johansson F Mertens F Mitelman 1991 Geographic heterogeneity of neoplasia-associated chromosome aberrations Genes Chromosom Cancer 3 1 7
21. EA Copelan EA McGuire 1995 The biology and treatment of acute lymphoblastic leukemia in adults Blood 85 1151 1168
22. L Bao X Wang J Ryder 2006 Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and Flt3 mutations Eur J Haematol 77 35 45
23. HM Kantarjian M Talpaz K Dhingra 1991 Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia Blood 78 2411 2418
24. Shaffer LG, Tommerup N. An international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Farmington, CT: Basel; Karger; 2005.
25. NC Cross JV Melo L Feng JM Goldman 1994 An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion MRNAs in haematological disorders Leukemia 8 186 189
26. R Simon YJ Lee 1982 Nonparametric confidence limits for survival probabilities and median survival time Cancer Treat Reps 66 37 42
27. BS Ko JL Tang W Tsai 2001 Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan Ann Hematol 80 510 515
28. JY Qiu W Zhu Y Zhang 2005 Cytogenetic and clinical study of Philadelphia chromosome positive adult acute leukemia. Chinese Zhongguo Shi Yan Xue Ye Xue Za Zhi 13 358 363
29. R Houot E Tavernier QH Le V Lheritier A Thiebaut X Thomas 2004 Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome Hematology 9 369 376
30. B Gleissner N Gokbuget CR Bartram 2002 Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German multicenter trial group and confirmed polymerase chain reaction analysis Blood 99 1536 1543